Presentation is loading. Please wait.

Presentation is loading. Please wait.

Efficacy of the oral chemoattractant receptor homologous molecule on TH2 cells antagonist BI 671800 in patients with seasonal allergic rhinitis  Norbert.

Published byทักษิณ วอชิงตัน Modified over 5 years ago

Similar presentations

Presentation on theme: "Efficacy of the oral chemoattractant receptor homologous molecule on TH2 cells antagonist BI 671800 in patients with seasonal allergic rhinitis  Norbert."— Presentation transcript:

1 Efficacy of the oral chemoattractant receptor homologous molecule on TH2 cells antagonist BI in patients with seasonal allergic rhinitis  Norbert Krug, MD, Abhya Gupta, MD, Philipp Badorrek, MD, Ruediger Koenen, MD, Meike Mueller, PhD, Anna Pivovarova, MSc, James Hilbert, PhD, Kristiane Wetzel, PhD, Jens M. Hohlfeld, MD, Chester Wood, MD  Journal of Allergy and Clinical Immunology  Volume 133, Issue 2, Pages e8 (February 2014) DOI: /j.jaci Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions

2 Fig 1 Adjusted means (SEs) for hourly TNSS AUC values. bid, Twice daily; qd, once daily. Journal of Allergy and Clinical Immunology  , e8DOI: ( /j.jaci ) Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions

3 Fig 2 Nasal eosinophil and cytokine values after 6 hours in the ECC. A, Absolute and percent nasal eosinophils count. B, Nasal IL-13 and eotaxin values. C, Nasal IL-4 and IL-5 values. bid, Twice daily; qd, once daily. Journal of Allergy and Clinical Immunology  , e8DOI: ( /j.jaci ) Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions

4 Fig 3 ESC median percentage change over time. bid, Twice daily; qd, once daily. Journal of Allergy and Clinical Immunology  , e8DOI: ( /j.jaci ) Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions

5 Fig E1 Study design. bid, Twice daily; qd, once daily.
Journal of Allergy and Clinical Immunology  , e8DOI: ( /j.jaci ) Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions

6 Fig E2 CONSORT diagram illustrating the flow of patients through the study. bid, Twice daily; qd, once daily. Journal of Allergy and Clinical Immunology  , e8DOI: ( /j.jaci ) Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions

7 Fig E3 Gating strategy for identification of eosinophils and ESC determination. A, Dot blot showing FSC versus side scatter was used to set a region (R1) around the granulocytes excluding low FSC and side scatter events. B, The resulting histogram showing the FL2 channel was used to gate the high autofluorescent population representing the eosinophils, and a marker was set above these cells (R2). C, This cell population was displayed in a FSC/side scatter dot blot gated on R1 and R2. From this cell population, 500 to 1000 events were recorded, and the mean FSC value of this cell population in R3 representing eosinophils was determined. Journal of Allergy and Clinical Immunology  , e8DOI: ( /j.jaci ) Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Download ppt "Efficacy of the oral chemoattractant receptor homologous molecule on TH2 cells antagonist BI 671800 in patients with seasonal allergic rhinitis  Norbert."

Similar presentations

Joint modeling of parentally reported and physician-confirmed wheeze identifies children with persistent troublesome wheezing Danielle C.M. Belgrave, MSc,

Joint modeling of parentally reported and physician-confirmed wheeze identifies children with persistent troublesome wheezing Danielle C.M. Belgrave, MSc,
A bioinformatics approach to identify patients with symptomatic peanut allergy using peptide microarray immunoassay Jing Lin, PhD, Francesca M. Bruni,

A bioinformatics approach to identify patients with symptomatic peanut allergy using peptide microarray immunoassay Jing Lin, PhD, Francesca M. Bruni,
The effects of an anti–IL-13 mAb on cytokine levels and nasal symptoms following nasal allergen challenge  Grant C. Nicholson, BSc, Harsha H. Kariyawasam,

The effects of an anti–IL-13 mAb on cytokine levels and nasal symptoms following nasal allergen challenge  Grant C. Nicholson, BSc, Harsha H. Kariyawasam,
Specificity and reproducibility of nasal biomarkers in patients with allergic rhinitis after allergen challenge chamber exposure  Philipp Badorrek, MD,

Specificity and reproducibility of nasal biomarkers in patients with allergic rhinitis after allergen challenge chamber exposure  Philipp Badorrek, MD,
Increased numbers of activated group 2 innate lymphoid cells in the airways of patients with severe asthma and persistent airway eosinophilia  Steven.

Increased numbers of activated group 2 innate lymphoid cells in the airways of patients with severe asthma and persistent airway eosinophilia  Steven.
Expression of FcγRIII (CD16) on human peripheral blood eosinophils increases in allergic conditions  Francis Davoine, MSc, Sophie Lavigne, MSc, Jamila.

Expression of FcγRIII (CD16) on human peripheral blood eosinophils increases in allergic conditions  Francis Davoine, MSc, Sophie Lavigne, MSc, Jamila.
Treating acute rhinosinusitis: Comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo  Eli O. Meltzer, MD, Claus Bachert,

Treating acute rhinosinusitis: Comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo  Eli O. Meltzer, MD, Claus Bachert,
Endotype-driven care pathways in patients with chronic rhinosinusitis

Endotype-driven care pathways in patients with chronic rhinosinusitis
Reduced TH1/TH17 CD4 T-cell numbers are associated with impaired purified protein derivative–specific cytokine responses in patients with HIV-1 infection 

Reduced TH1/TH17 CD4 T-cell numbers are associated with impaired purified protein derivative–specific cytokine responses in patients with HIV-1 infection 
Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5– grass pollen tablet for seasonal allergic rhinitis  Alain Didier, MD,

Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5– grass pollen tablet for seasonal allergic rhinitis  Alain Didier, MD,
Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 

Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 
Fluticasone furoate nasal spray: A single treatment option for the symptoms of seasonal allergic rhinitis  Harold B. Kaiser, MD, Robert M. Naclerio, MD,

Fluticasone furoate nasal spray: A single treatment option for the symptoms of seasonal allergic rhinitis  Harold B. Kaiser, MD, Robert M. Naclerio, MD,
Immunologic defects in 22q11.2 deletion syndrome

Immunologic defects in 22q11.2 deletion syndrome
Stephen J. Fowler, MD, Gaël Tavernier, PhD, Robert Niven, MD 

Stephen J. Fowler, MD, Gaël Tavernier, PhD, Robert Niven, MD 
Dorothy M. Ryan, MD, Stephen J. Fowler, MD, Robert M. Niven, MD 

Dorothy M. Ryan, MD, Stephen J. Fowler, MD, Robert M. Niven, MD 
Is 9 more than 2 also in allergic airway inflammation?

Is 9 more than 2 also in allergic airway inflammation?
Bruce M. Prenner, MD, Bobby Q. Lanier, MD, David I

Bruce M. Prenner, MD, Bobby Q. Lanier, MD, David I
Children with allergic and nonallergic rhinitis have a similar risk of asthma  Bo Lund Krogsgaard Chawes, MD, Klaus Bønnelykke, MD, PhD, Eskil Kreiner-Møller,

Children with allergic and nonallergic rhinitis have a similar risk of asthma  Bo Lund Krogsgaard Chawes, MD, Klaus Bønnelykke, MD, PhD, Eskil Kreiner-Møller,
Severe atopic dermatitis is characterized by selective expansion of circulating TH2/TC2 and TH22/TC22, but not TH17/TC17, cells within the skin-homing.

Severe atopic dermatitis is characterized by selective expansion of circulating TH2/TC2 and TH22/TC22, but not TH17/TC17, cells within the skin-homing.
Natural regulatory T cells in isolated early responders compared with dual responders with allergic asthma  Takashi Kinoshita, MD, Adrian Baatjes, MSc,

Natural regulatory T cells in isolated early responders compared with dual responders with allergic asthma  Takashi Kinoshita, MD, Adrian Baatjes, MSc,

Similar presentations

Ads by Google